Vikki Lovvoll

Vikki Lovvoll brings 25 years of experience as a pharmaceutical data science professional to her role as Vice President of Business Operations at Braeburn. In this role, she oversees advanced analytics, forecasting, market research, data operations, and reporting.

Previously, Vikki served as Executive Director of Advanced Analytics at Biohaven/Pfizer, where she played a key role in launching and supporting the Pfizer acquisition of the migraine portfolio (Nurtec/Zavzpret). Her extensive experience also includes over 15 years at Bristol-Myers Squibb, where she advanced to hold U.S. and Global leadership positions as Executive Director overseeing Forecasting , Insights & Analytics across multiple therapeutic areas, including Neuroscience (MDD, BD, Alzheimer’s), Virology (HIV), Immunoscience (Hematology), and Organ Transplant. Vikki received her B.S. from The College of New Jersey and serves as a member of the Institutional Review Board of Princeton University.